Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Non Operating Income: 2020-2023

Historic Non Operating Income for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $2.3 million.

  • Therapeutics' Non Operating Income rose 58.18% to $2.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.3 million, marking a year-over-year increase of 424.48%. This contributed to the annual value of $10.3 million for FY2023, which is 424.48% up from last year.
  • Latest data reveals that Therapeutics reported Non Operating Income of $2.3 million as of Q4 2023, which was down 8.12% from $2.5 million recorded in Q3 2023.
  • Therapeutics' Non Operating Income's 5-year high stood at $3.1 million during Q2 2023, with a 5-year trough of -$275,000 in Q2 2022.
  • Its 3-year average for Non Operating Income is $1.0 million, with a median of $376,000 in 2022.
  • The largest annual percentage gain for Therapeutics' Non Operating Income in the last 5 years was 1,309.52% (2022), contrasted with its biggest fall of 848.28% (2022).
  • Over the past 4 years, Therapeutics' Non Operating Income (Quarterly) stood at $549,000 in 2020, then slumped by 80.87% to $105,000 in 2021, then spiked by 1,309.52% to $1.5 million in 2022, then spiked by 58.18% to $2.3 million in 2023.
  • Its Non Operating Income stands at $2.3 million for Q4 2023, versus $2.5 million for Q3 2023 and $3.1 million for Q2 2023.